• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

The inventory of GRAS notices provides information about GRAS notices filed since 1998, when FDA received its first GRAS notice. As of October 17, 2016, the GRAS final rule (81 FR 54960; August 17, 2016) requires a specific format for a GRAS notice. Prior to that date, FDA processed GRAS notices under the framework of the GRAS proposed rule (62 FR 18938; April 17, 1997). Notices received prior to the effective date of the GRAS final rule provide examples for potential notifiers for the types of information that may support a GRAS conclusion. In the inventory, notices follow the requirements for the format and content of a GRAS notice as of the effective date of the GRAS final rule.

The inventory notes what type of response letter the FDA sent in response to the notice. Notifiers often resubmit notices that FDA previously ceased to evaluate at the notifier’s request, and resubmitted notices commonly receive a letter indicating FDA has no questions, after addressing deficiencies. In the inventory, entries for notices that were later resubmitted link to the newer entry in the final column. Newer entries for notices that were resubmitted include a link to the previous submission below the substance name.

Some GRNs that FDA previously ceased to evaluate at the notifier’s request were later resubmitted as a food additive petition. For each of these cases, the GRN detail page links to the food additive petition.

After issuing a response letter, we may issue a subsequent letter as circumstances warrant. The issue dates of any subsequent letters are listed under the column, "Date of add’l correspondence.”

As of July 2025, FDA is posting notices in a Docket at www.regulations.gov. In these cases, the link for the notices will take you to the document posted at www.regulations.gov. We will update this information approximately monthly. More information about this inventory is available on the GRAS Notice Inventory Introduction page.


Search and display hints:

  • Select the specific GRN number below to view additional details about any GRAS Notice.
  • To sort by a specific field, click on the column header for that field.
  • To browse the records, use the Show All, First/Previous/Next/Last, and Jump To options at the bottom of the data table.
  • To search for a specific substance/term, enter the term in the Search box and select Show Items to display only those records that contain the selected term. (The search results also includes terms not shown on this page, but included in the full record on the detail page.)
  • The search results will return hits of records containing words that include the search term. For example, a search for the color red will return results that include terms such as reduce, ingredient, and cultured. To limit results to only the searched term, place a space before and after the word in the basic search or in the advanced search “this exact phrase” field.
Download GRAS Notices data in Microsoft Excel web format Download data from this searchable database in Excel format. If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Search within these results
Records Found: 1279 Show All Page 1 of 26
GRN No. Substance Date of closure
(sorted Z-A)
FDA's Letter Date of add'l correspondence Resubmitted as GRN No.
  1248
Yeast biomass produced by Kluyveromyces marxianus CCTCC M 20211265 Sep 23, 2025 FDA has no questions (in PDF) (236 kB)
  1252
Saccharomyces cerevisiae "BY-1568" Sep 23, 2025 FDA has no questions (162 kB)
  1251
Saccharomyces cerevisiae expressing a gene encoding a cysteine-thiol lyase from Staphylococcus hominis (S. cerevisiae "OYR-290") Sep 23, 2025 FDA has no questions (in PDF) (164 kB)
  1246
Saccharomyces cerevisiae BY-1248 Sep 22, 2025 FDA has no questions (in PDF) (172 kB)
  1237
β-glucanase enzyme preparation produced by Talaromyces versatilis Sep 22, 2025 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (146 kB)
  1247
β-Lactoglobulin produced by Kluyveromyces lactis CCTCC M20241460 Sep 19, 2025 FDA has no questions (in PDF) (209 kB)
  1241
β-lactoglobulin produced by Aspergillus oryzae Sep 16, 2025 FDA has no questions (in PDF) (253 kB)
  1249
Ovalbumin produced by Trichoderma reesei ATCC 13631 Sep 16, 2025 FDA has no questions (in PDF) (206 kB)
  1235
Bifidobacterium lactis CCTCC M 2014588 Sep 2, 2025 FDA has no questions (in PDF) (210 kB)
  1243
Bacillus coagulans M2017813 spore preparation Aug 21, 2025 FDA has no questions (in PDF) (205 kB)
  1227
Korean red ginseng (Panax ginseng C.A. Meyer) root extract Aug 21, 2025 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (116 kB)
  1210
Glucosyltransferase enzyme preparation produced by Bacillus subtilis expressing the gene encoding glucosyltransferase from Streptococcus salivarius Aug 15, 2025 FDA has no questions (in PDF) (171 kB)
  1229
Levilactobacillus brevis ATCC SD-7285 Aug 15, 2025 FDA has no questions (149 kB)
  1220
Mycelial biomass from Pleurotus pulmonarius Aug 15, 2025 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (138 kB)
  1232
Lacticaseibacillus paracasei DSMZ 28047 Aug 6, 2025 FDA has no questions (252 kB)
  1244
Lactiplantibacillus plantarum DSM 21380 Aug 5, 2025 FDA has no questions (in PDF) (174 kB)
  1245
Lactiplantibacillus plantarum DSM 21379 Aug 5, 2025 FDA has no questions (in PDF) (173 kB)
  1242
Short-chain fructooligosaccharides Jul 14, 2025 FDA has no questions (in PDF) (94 kB)
  1234
Sansho (Zanthoxylum piperitum) pepper extract Jul 14, 2025 FDA has no questions (in PDF) (86 kB)
  1231
Bacillus velezensis PTA-127359 Jul 11, 2025 FDA has no questions (in PDF) (92 kB)
  1240
Lacticaseibacillus rhamnosus ATCC PTA-126815 Jul 8, 2025 FDA has no questions (in PDF) (92 kB)
  1233
Sansho (Zanthoxylum piperitum) pepper distillate Jul 8, 2025 FDA has no questions (in PDF) (85 kB)
  1238
2'-fucosyllactose Jun 17, 2025 FDA has no questions (in PDF) (113 kB)
  1230
Vanillin preparation produced by Escherichia coli BL21(DE3) SI-VAN1 Jun 11, 2025 FDA has no questions (in PDF) (101 kB)
  1239
Bifidobacterium animalis subsp. lactis PTA-126817 Jun 11, 2025 FDA has no questions (in PDF) (92 kB)
  1236
Algal oil (≥40% docosahexaenoic acid) from Aurantiochytrium limacinum H Sc-01 Jun 10, 2025 FDA has no questions (in PDF) (240 kB)
  1221
Heyndrickxia coagulans NRRL B-67744 Jun 9, 2025 FDA has no questions (in PDF) (101 kB)
  1215
Bacteriophage (phage) preparation specific to Listeria monocytogenes Jun 6, 2025 FDA has no questions (in PDF) (163 kB)
  1223
Sakura (Prunus serrulata Lindl.) flower distillate Jun 3, 2025 FDA has no questions (in PDF) (84 kB)
  1224
Sakura (Prunus serrulata Lindl.) flower extract Jun 3, 2025 FDA has no questions (in PDF) (89 kB)
  1225
Sakura (Prunus speciosa) leaf distillate Jun 3, 2025 FDA has no questions (in PDF) (82 kB)
  1209
Algal oil (≥35% docosahexaenoic acid) from Schizochytrium limacinum A2 May 7, 2025 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (378 kB)
  1214
Bacillus clausii UBBC-07 spore preparation May 7, 2025 FDA has no questions (in PDF) (179 kB)
  1217
Algal oil (≥40% docosahexaenoic acid) from Aurantiochytrium limacinum CCAP A1 May 7, 2025 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (202 kB)
  1219
Recombinant bovine lactoferrin isolate produced by Komagataella phaffii M020 expressing the gene encoding bovine lactoferrin May 7, 2025 FDA has no questions (in PDF) (580 kB)
  1222
Saccharomyces cerevisiae OYR-542 May 5, 2025 FDA has no questions (in PDF) (224 kB)
  1208
Lacto-N-triose II Apr 29, 2025 FDA has no questions (in PDF) (285 kB)
  1218
Bacillus subtilis NRRL 68054 Apr 29, 2025 FDA has no questions (in PDF) (192 kB)
  1207
Brazzein preparation produced by Aspergillus oryzae 90402 expressing a gene encoding for brazzein from Pentadiplandra brazzeana Apr 10, 2025 FDA has no questions (in PDF) (234 kB) May 23, 2025
  1205
Lactiplantibacillus plantarum DR7 Mar 24, 2025 FDA has no questions (in PDF) (174 kB)
  1192
Tannase enzyme preparation produced by Aspergillus oryzae Mar 14, 2025 FDA has no questions (in PDF) (280 kB)
  1197
Fructanase enzyme preparation produced by Trichoderma reesei AR-577 expressing the gene encoding fructanase from Lactobacillus crispatus
   (Resubmission of GRN 1121)
Mar 14, 2025 FDA has no questions (in PDF) (257 kB)
  1185
Algal oil (≥35% docosahexaenoic acid) from Schizochytrium sp. " FJRK-SCH3" Mar 14, 2025 Notice does not provide a basis for a GRAS determination (in PDF) (204 kB)
  1201
Lipase enzyme preparation produced by Komagataella phaffii expressing a gene encoding lipase from Yarrowia lipolytica Mar 10, 2025 FDA has no questions (in PDF) (183 kB)
  1202
Soy leghemoglobin preparation from a strain of Komagataella phaffii Mar 7, 2025 FDA has no questions (in PDF) (246 kB)
  1195
Chymosin enzyme preparation produced by Aspergillus niger expressing a gene encoding chymosin from Erinaceus europaeus Mar 6, 2025 FDA has no questions (in PDF) (334 kB) Jul 3, 2025
  1196
Triacylglycerol lipase enzyme preparation produced by Trichoderma reesei expressing a gene encoding an engineered triacylglycerol lipase from Thermomyces lanuginosus
   (Resubmission of GRN 1150)
Mar 3, 2025 FDA has no questions (in PDF) (185 kB)
  1206
Rebaudioside M produced by enzymatic treatment of rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni Feb 28, 2025 FDA has no questions (in PDF) (253 kB)
  1187
Polygalacturonase enzyme preparation produced by Trichoderma reesei expressing a gene encoding polygalacturonase from Aspergillus luchuensis mut kawachii
   (Resubmission of GRN 1110)
Feb 28, 2025 FDA has no questions (in PDF) (180 kB)
  1200
β-lactoglobulin produced by Komagataella phaffii strain VIPLA Feb 28, 2025 FDA has no questions (in PDF) (289 kB)

Show All 

jump to page of 26 


GRN No. Substance Date of closure
(sorted Z-A)
FDA's Letter Date of add'l correspondence Resubmitted as GRN No.
-
-